T1	Entity 14 40	transcriptional regulation
T2	Cluster2 44 66	pancreatic development
T3	Entity 120 151	beta cell replacement therapies
T4	Entity 156 178	patients with diabetes
T5	Cluster15 201 231	key transcriptional regulators
T6	Entity 260 273	mouse studies
T7	Entity 280 315	rare, naturally occurring mutations
T8	Entity 386 407	homozygosity analysis
T9	Entity 412 429	Sanger sequencing
T10	Entity 433 435	37
T11	Entity 436 459	consanguineous patients
T12	Cluster11 465 492	permanent neonatal diabetes
T13	Cluster1 507 527	homozygous mutations
T14	Entity 531 533	29
T15	Entity 534 560	transcription factor genes
T16	Entity 575 604	murine pancreatic development
T17	Cluster1 620 640	homozygous mutations
T18	Cluster3 644 645	7
T19	Entity 646 661	different genes
T20	Entity 665 667	11
T21	Entity 668 686	unrelated patients
T22	Entity 721 738	etiological genes
T23	Cluster6 743 760	neonatal diabetes
T24	Entity 796 807	development
T25	Entity 811 829	the human pancreas
T26	Entity 831 852	The similar phenotype
T27	Entity 856 868	the patients
T28	Cluster14 874 893	recessive mutations
T29	Entity 898 902	mice
T30	Entity 908 920	inactivation
T31	Entity 924 959	a transcription factor gene support
T32	Cluster2 998 1020	pancreatic development
T33	Cluster7 1063 1084	beta cell development
T34	Entity 1045 1058	rodent models
T35	Cluster1 1118 1138	Homozygous mutations
T36	Cluster3 1142 1147	seven
T37	Entity 1148 1180	pancreatic transcription factors
T38	Cluster6 1187 1204	neonatal diabetes
T39	Entity 1258 1271	five patients
T40	Entity 1207 1243	Homozygous NKX2-2 and MNX1 mutations
T41	Entity 1316 1353	murine and human pancreas development
T42	Entity 1356 1374	Similar phenotypes
T43	Cluster7 1412 1433	beta cell development
T44	Entity 1444 1462	a large collection
T45	Entity 1466 1489	consanguineous patients
T46	Cluster11 1495 1522	permanent neonatal diabetes
T47	Cluster14 1577 1596	recessive mutations
T48	Entity 1600 1621	transcription factors
T49	Entity 1647 1675	mouse pancreatic development
T50	Cluster3 1691 1696	seven
T52	Cluster6 1741 1758	neonatal diabetes
T53	Cluster4 701 707	NKX2-2
T54	Cluster5 712 716	MNX1
T55	Cluster4 1283 1289	NKX2-2
T56	Cluster5 1294 1298	MNX1
T57	Entity 1378 1383	mouse
T58	Entity 1388 1391	man
T59	Entity 1392 1400	validate
T60	Cluster4 1770 1776	NKX2-2
T61	Cluster5 1781 1785	MNX1
T62	Cluster2 796 829	development of the human pancreas
T63	Cluster10 1142 1180	seven pancreatic transcription factors
T64	Cluster10 1691 1729	seven pancreatic transcription factors
T65	Entity 436 492	consanguineous patients with permanent neonatal diabetes
T66	Entity 1466 1522	consanguineous patients with permanent neonatal diabetes
T67	Cluster15 329 334	their
T68	Cluster16 433 492	37 consanguineous patients with permanent neonatal diabetes
T69	Cluster16 1444 1522	a large collection of consanguineous patients with permanent neonatal diabetes
T71	Cluster17 778 783	their
T72	Cluster17 1770 1785	NKX2-2 and MNX1
T73	Cluster17 1283 1298	NKX2-2 and MNX1
T70	Cluster17 701 716	NKX2-2 and MNX1
T51	Entity 1697 1729	pancreatic transcription factors
T74	Cluster10 1730 1734	that
